What is the treatment for cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cluster Headaches

For acute cluster headache attacks, initiate high-flow oxygen at 100% and 12 L/min via non-rebreather mask for 15 minutes, or subcutaneous sumatriptan 6 mg as first-line therapy; for prevention of episodic cluster headache, galcanezumab is the first-line prophylactic treatment. 1

Acute Treatment Algorithm

First-Line Options (Choose One)

High-flow oxygen therapy is the preferred initial treatment for most patients:

  • Administer 100% oxygen at 12 L/min via non-rebreather mask for 15 minutes 1
  • 78% of patients achieve pain relief compared to 20% with placebo 1, 2
  • Critical pitfall: Flow rates below 12 L/min are insufficient—proper equipment and adequate flow rates are essential for efficacy 1
  • Safe with no important adverse events 2

Subcutaneous sumatriptan 6 mg provides the most rapid relief:

  • 49% of patients experience pain relief within 10 minutes and 74-75% within 15 minutes 1
  • Fastest-acting pharmacologic option available 1

Alternative Acute Options

Intranasal zolmitriptan 10 mg serves as an alternative when subcutaneous sumatriptan is contraindicated or not tolerated 1

Noninvasive vagus nerve stimulation can be considered for short-term treatment of episodic cluster headache 1

Medications to Avoid

Never use oral ergot alkaloids, opioids, or barbiturates for cluster headache treatment due to poor efficacy, potential toxicity, and dependency risks 1

Preventive Treatment Algorithm

First-Line Prophylaxis

Galcanezumab is recommended as first-line prophylactic treatment for episodic cluster headache based on the strongest available evidence 1

  • Important limitation: Galcanezumab is NOT effective for chronic cluster headache and should not be prescribed for this population 1
  • Monoclonal antibodies may take 3-6 months to become fully effective 1

Second-Line Prophylaxis

Verapamil is commonly used for prevention, though evidence is insufficient for a strong recommendation 1

  • Remains a mainstay of prophylactic therapy in clinical practice 3, 4, 5
  • Oral preventive medications may take 2-3 months to become effective 1

Bridging Therapy

While waiting for preventive medications to take effect, consider:

  • Oral corticosteroids 3, 4
  • Suboccipital nerve blocks 3, 4

Treatment Selection Based on Cluster Headache Type

For episodic cluster headache:

  • Acute: High-flow oxygen or subcutaneous sumatriptan 1
  • Preventive: Galcanezumab as first-line 1

For chronic cluster headache:

  • Acute: High-flow oxygen or subcutaneous sumatriptan 1
  • Preventive: Verapamil (galcanezumab is ineffective) 1
  • Consider neuromodulation for treatment-refractory cases 3

Practical Implementation Considerations

Timing of acute treatment is critical—initiate therapy at the earliest sign of attack onset for maximum efficacy 1, 3

Trigger avoidance: Counsel patients to avoid nitrate-containing foods such as processed meats and aged cheeses, which may trigger attacks 1

Equipment requirements: Ensure patients have access to proper non-rebreather masks and oxygen delivery systems capable of 12-15 L/min flow rates 1, 6

References

Guideline

Cluster Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Research

Diagnosis and treatment of cluster headache.

Seminars in neurology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.